About Zeiss

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 6.4 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2019).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership.

With over 31,000 employees, ZEISS is active globally in almost 50 countries with around 60 sales and service companies, 30 production sites and 25 development sites. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Contact

Carl-Zeiss-Straße 22
73447 Oberkochen
Germany

info.de@zeiss.com
+49 7364 20-0

https://www.zeiss.com/

Toepassingen

Aanvullen

Technologieën

Aanvullen

Thema’s

Aanvullen

Gepubliceerde artikelen

67.5 million venture capital for start-ups

Good news for Dutch start-ups in the early phase. From now on…
6 oktober 2020/door Aurélie Veltema

Professional video offer for iMNC2020 exhibitors

The exhibitors have started to build their exhibitor booth for…
1 oktober 2020/door Aurélie Veltema

Call for your input: Smart industry project NanoBio

The NanoBio research group is involved in many different application-…
25 september 2020/door Aurélie Veltema

First pre-event iMNC2020 on public-private collaboration very successful – Up next the Nano4Agri/Food event

On September 23, the iMNC2020 hosted the first pre-meeting for…
25 september 2020/door Aurélie Veltema

Nanotechnology roadmap update October 2020

At the end of 2019, the vision for Nanotechnology into the future…
15 september 2020/door Aurélie Veltema

Register now: First iMNC2020 pre-meeting on public private collaboration in times of pandemic

On September 23rd the first of the five pre-meetings will…
14 september 2020/door Aurélie Veltema

iMNC2020 brings science and industry together: pre-events, abstract submission and registration open

The International MicroNanoConference brings together science…
11 september 2020/door Aurélie Veltema

Publieke investeringen vergroten economische groei en toekomstige welvaart. Kabinet lanceert Nationaal Groeifonds

Ook volgende generaties moeten kunnen wonen in een Nederland…
10 september 2020/door Aurélie Veltema

NODE by Slush – inschrijving voor start-ups

Bent u een innovatieve start-up en klaar om op te schalen? Wilt…
7 september 2020/door Aurélie Veltema

Designer blood vessels for treating cardiovascular diseases

Cardiovascular diseases, such as coronary heart disease, are…
28 augustus 2020/door Aurélie Veltema

NWO Take-off phase 1 – Feasability studies WO

Researchers from NWO recognized university institutions and innovative…
28 augustus 2020/door Aurélie Veltema

First exhibitors for iMNC2020

The first exhibitors have join the international MicroNanoConference…
24 augustus 2020/door Aurélie Veltema